Fighting the coronavirus pandemic drives you. We are in this fight together.
We are committed to helping drive your efforts to eliminate coronavirus by delivering purposefully built laboratory solutions that may play a key role in helping people return to work, school and the new normal around the world.
We are grateful to the friends and family of Beckman Coulter associates around the world who are on the front-lines during the fight against COVID-19. We thank and celebrate our healthcare heroes.
Latest Blog Articles
Medical Value of SARS-CoV-2 Spike Protein
Get high medical value with Access SARS-CoV-2 IgG assay as it detects antibodies against the virus spike protein.
The Need for Efficiency in SARS-CoV-2 Antibody Testing
Efficiency may be even more important for labs during this pandemic. Learn what features drive efficiency in COVID-19 testing.
Building a Strong Foundation for Preparedness
Find out how organizations can mitigate a pandemic’s interruption of operations and disruption to the provision of critical functions.
See all our Blog Articles Covering the Coronavirus Pandemic
View all our SARS-CoV-2 articles, news and resources focused on elevating clinical laboratory performance and advancing patient care.
Access SARS-CoV-2 IgG Antibody Test
NOW AVAILABLEFight Coronavirus
Access SARS-CoV-2 IgM Antibody Test
NOW AVAILABLEFight Coronavirus
Sign Up for UpdatesSign up
Infographic Testing for the coronavirus
The news is full of information about a variety of tests. Some tests diagnose COVID-19; others identify novel coronavirus antibodies in the blood and serum. Here is a quick look at what test to use when and their benefits.Download
Peer-Reviewed Clinical Study Detection of SARS-CoV-2-specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
In this study of post-hospital discharge COVID-19 patients, researchers discovered SARS-CoV-2-specific humoral immunity and cellular immunity through the detection of antibodies specific to the receptor-binding domain of the coronavirus spike protein (S-RBD).Read study
Webinar Clinical Value of Spike Protein Antibodies in Serology Testing
The Beckman Coulter Access IgG assay targets the Receptor Binding Domain (RBD) of the Spike (S) protein. Find out more about the clinical value of the Spike Protein Antibody in this comprehensive, interactive data overview.Watch webinar
Frequently Asked Questions
- - identifying individuals who previously had COVID-19
- - tests are acceptable to be used in the manufacture of COVID-19 convalescent plasma
2Ling Ni, Fang Ye, Meng-Li Cheng, Yu Feng, Yong-Qiang Deng, Hui Zhao, Peng Wei, Jiwan Ge, Mengting Gou, Xiaoli Li, Lin Sun, Tianshu Cao, Pengzhi Wang, Chao Zhou, Rongrong Zhang, Peng Liang, Han Guo, Xinquan Wang, Cheng-Feng Qin, Fang Chen, Chen Dong. “Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals” https://doi.org/10.1016/j.immuni.2020.04.023
Not all products and solutions mentioned on this page are available in all countries.